Antineuroinflammatory Effects of Modified Wu-Zi-Yan-Zong Prescription in <i>β</i>-Amyloid-Stimulated BV2 Microglia via the NF-<i>κ</i>B and ERK/p38 MAPK Signaling Pathways

<div><i>HPLC analysis of modified Wu-Zi-Yan-Zong prescription (MWP)</i>. HPLC fingerprint of MWP (see Table <a href="../tab2/">2</a>).</div>

Evidence-Based Complementary and Alternative Medicine

fig1

Figure 1

Figure 1: Antineuroinflammatory Effects of Modified Wu-Zi-Yan-Zong Prescription in <i>β</i>-Amyloid-Stimulated BV2 Microglia via the NF-<i>κ</i>B and ERK/p38 MAPK Signaling Pathways 

Figure 1 | Antineuroinflammatory Effects of Modified Wu-Zi-Yan-Zong Prescription in β-Amyloid-Stimulated BV2 Microglia via the NF-κB and ERK/p38 MAPK Signaling Pathways 